Wide Ranks

MXCT

MaxCyte, Inc.

3.52

Top Statistics
Market Cap 371 M Forward PE -9.08 Revenue Growth 2.00 %
Current Ratio 9.81 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -78.37 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -5.61 Enterprise / Revenue 5.17 Price To Sales Trailing12 Months 8.14
Profitability
Profit Margins -78.37 % Operating Margins -172.13 %
Balance Sheet
Total Cash 153 M Total Cash Per Share 1.46 Total Debt 18 M
Total Debt To Equity 8.59 Current Ratio 9.81 Book Value Per Share 2.03
All Measures
Short Ratio 672.00 % Message Board Id finmb_4048262 Shares Short Prior Month 3 M
Return On Equity -0.1600 City Rockville Uuid 99edb1ce-9d5d-37b7-967d-699d6c90ba1a
Previous Close 3.38 First Trade Date Epoch Utc 1 B Book Value 2.03
Beta 1.16 Total Debt 18 M Volume 769446
Price To Book 1.74 Fifty Two Week Low 3.17 Total Cash Per Share 1.46
Total Revenue 45 M Shares Short Previous Month Date 1 B Target Median Price 9.50
Audit Risk 2 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -172.13 % Target Mean Price 9.25 Net Income To Common -35736000
Short Percent Of Float 0.0318 Implied Shares Outstanding 107 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 939300 Average Volume10days 939300
Total Cash 153 M Next Fiscal Year End 1 B Revenue Per Share 0.4370
Held Percent Insiders 0.0150 Ebitda Margins -92.18 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Share Holder Rights Risk 8
Regular Market Previous Close 3.38 Target Low Price 7.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 3.70 Open 3.38 Free Cashflow -7745100
State MD Dividend Yield 0.00 % Return On Assets -0.1125
Time Zone Short Name EST Board Risk 8 Trailing Eps -0.3400
Day Low 3.38 Address1 9713 Key West Avenue Shares Outstanding 105 M
Compensation Risk 8 Price Hint 4 Target High Price 11.00
Website https://www.maxcyte.com 52 Week Change -0.2589 Average Volume 475710
Forward Eps -0.3900 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 898.90 % Is_sp_500 False Regular Market Day High 3.58
Profit Margins -78.37 % Debt To Equity 8.59 Fifty Two Week High 5.54
Day High 3.58 Shares Short 3 M Regular Market Open 3.38
Industry Key medical-devices Earnings Growth 0.00 % Enterprise To Revenue 5.17
Revenue Growth 2.00 % Shares Percent Shares Out 0.0315 Operating Cashflow -18808000
Currency USD Time Zone Full Name America/New_York Market Cap 371 M
Is_nasdaq_100 False Zip 20850 Quote Type EQUITY
Industry Medical Devices Long Name MaxCyte, Inc. Overall Risk 7
Regular Market Day Low 3.38 Held Percent Institutions 0.7052 Current Price 3.52
Address2 Suite 400 Enterprise To Ebitda -5.61 Financial Currency USD
Current Ratio 9.81 Gross Margins 85.98 % Industry Disp Medical Devices
Number Of Analyst Opinions 4 Country United States Float Shares 96 M
Two Hundred Day Average 4.15 Governance Epoch Date 1 B Enterprise Value 235 M
Price To Sales Trailing12 Months 8.14 Forward PE -9.08 Regular Market Volume 769446
Ebitda -42032000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally.

Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering.

The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols.

It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing.

MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.